Legal Representation
Attorney
Timothy H. Hiebert
USPTO Deadlines
Application History
34 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 20, 2021 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Dec 20, 2021 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| May 18, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 17, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| May 17, 2021 | EX5G | S | SOU EXTENSION 5 GRANTED |
| May 6, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 6, 2021 | EXT5 | S | SOU EXTENSION 5 FILED |
| Nov 13, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 11, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 11, 2020 | EXT4 | S | SOU EXTENSION 4 FILED |
| Nov 11, 2020 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Jun 14, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jun 14, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jun 14, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Apr 16, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 14, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 14, 2020 | EXT3 | S | SOU EXTENSION 3 FILED |
| Apr 14, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Nov 2, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Oct 31, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 31, 2019 | EXT2 | S | SOU EXTENSION 2 FILED |
| Oct 31, 2019 | EX2G | S | SOU EXTENSION 2 GRANTED |
| May 15, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 13, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 13, 2019 | EXT1 | S | SOU EXTENSION 1 FILED |
| May 13, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Nov 13, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sep 18, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Sep 18, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Aug 29, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Aug 10, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Aug 9, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| May 1, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 24, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005